Ophthalmic Drugs Market is poised to register a CAGR of 6.4% during the forecast period 2022 to 2028.
Ophthalmic medications are formulations used to treat eye illnesses such as cataract, glaucoma, colour blindness, diabetic macular edoema, cytomegalovirus (CMV) retinitis, and age-related macular degeneration (AMD). The rise in the elderly population, the prevalence of eye diseases such as glaucoma, cataracts, and macular degeneration, the surge in ophthalmic drug demand, and the increase in investment in research and development activities by various healthcare companies are the key factors driving the growth of the global ophthalmic drugs market.
Request for a FREE Sample on - [ Ссылка ]
Follow us on:
Facebook - [ Ссылка ]
LinkedIn - [ Ссылка ]
Twitter - [ Ссылка ]
